BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27569089)

  • 1. Anticancer activity of Honokiol against lymphoid malignant cells via activation of ROS-JNK and attenuation of Nrf2 and NF-κB.
    Gao DQ; Qian S; Ju T
    J BUON; 2016; 21(3):673-9. PubMed ID: 27569089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kB pathway inhibition.
    Zha J; Chen F; Dong H; Shi P; Yao Y; Zhang Y; Li R; Wang S; Li P; Wang W; Xu B
    J Transl Med; 2014 Jun; 12():163. PubMed ID: 24915933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional effects of honokiol as an anti-inflammatory and anti-cancer drug in human oral squamous cancer cells and xenograft.
    Cho JH; Jeon YJ; Park SM; Shin JC; Lee TH; Jung S; Park H; Ryu J; Chen H; Dong Z; Shim JH; Chae JI
    Biomaterials; 2015; 53():274-84. PubMed ID: 25890726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo.
    Huang K; Chen Y; Zhang R; Wu Y; Ma Y; Fang X; Shen S
    Cell Death Dis; 2018 Feb; 9(2):157. PubMed ID: 29410403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
    Tse AK; Wan CK; Shen XL; Yang M; Fong WF
    Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raddeanin A, a natural triterpenoid saponin compound, exerts anticancer effect on human osteosarcoma via the ROS/JNK and NF-κB signal pathway.
    Ma B; Zhu J; Zhao A; Zhang J; Wang Y; Zhang H; Zhang L; Zhang Q
    Toxicol Appl Pharmacol; 2018 Aug; 353():87-101. PubMed ID: 29847772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia.
    Ishikawa C; Arbiser JL; Mori N
    Biochim Biophys Acta; 2012 Jul; 1820(7):879-87. PubMed ID: 22465179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel CHOP activator LGH00168 induces necroptosis in A549 human lung cancer cells via ROS-mediated ER stress and NF-κB inhibition.
    Ma YM; Peng YM; Zhu QH; Gao AH; Chao B; He QJ; Li J; Hu YH; Zhou YB
    Acta Pharmacol Sin; 2016 Sep; 37(10):1381-1390. PubMed ID: 27264312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Honokiol-induced apoptosis of human non-Hodgkin lymphoma Raji cells and its possible mechanism].
    Chen W; Lin GW; Zhang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1918-21. PubMed ID: 22126780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japonicone A suppresses growth of Burkitt lymphoma cells through its effect on NF-κB.
    Li X; Yang X; Liu Y; Gong N; Yao W; Chen P; Qin J; Jin H; Li J; Chu R; Shan L; Zhang R; Zhang W; Wang H
    Clin Cancer Res; 2013 Jun; 19(11):2917-28. PubMed ID: 23620411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-O-methylhonokiol inhibits colon tumor growth via p21-mediated suppression of NF-κB activity.
    Oh JH; Ban JO; Cho MC; Jo M; Jung JK; Ahn B; Yoon DY; Han SB; Hong JT
    J Nutr Biochem; 2012 Jul; 23(7):706-15. PubMed ID: 21820300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honokiol protects pancreatic β cell against high glucose and intermittent hypoxia-induced injury by activating Nrf2/ARE pathway in vitro and in vivo.
    Li CG; Ni CL; Yang M; Tang YZ; Li Z; Zhu YJ; Jiang ZH; Sun B; Li CJ
    Biomed Pharmacother; 2018 Jan; 97():1229-1237. PubMed ID: 29145148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway.
    Ahn KS; Sethi G; Shishodia S; Sung B; Arbiser JL; Aggarwal BB
    Mol Cancer Res; 2006 Sep; 4(9):621-33. PubMed ID: 16966432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-psoriatic effects of Honokiol through the inhibition of NF-κB and VEGFR-2 in animal model of K14-VEGF transgenic mouse.
    Wen J; Wang X; Pei H; Xie C; Qiu N; Li S; Wang W; Cheng X; Chen L
    J Pharmacol Sci; 2015 Jul; 128(3):116-24. PubMed ID: 26220468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies.
    Mędra A; Witkowska M; Majchrzak A; Cebula-Obrzut B; Bonner MY; Robak T; Arbiser JL; Smolewski P
    Molecules; 2016 Jul; 21(8):. PubMed ID: 27483232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnolol suppresses the proliferation and invasion of cholangiocarcinoma cells via inhibiting the NF-κB signaling pathway.
    Zhang FH; Ren HY; Shen JX; Zhang XY; Ye HM; Shen DY
    Biomed Pharmacother; 2017 Oct; 94():474-480. PubMed ID: 28779709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-κB.
    Park MH; Choi MS; Kwak DH; Oh KW; Yoon DY; Han SB; Song HS; Song MJ; Hong JT
    Prostate; 2011 Jun; 71(8):801-12. PubMed ID: 21456063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnolol inhibits angiogenesis by regulating ROS-mediated apoptosis and the PI3K/AKT/mTOR signaling pathway in mES/EB-derived endothelial-like cells.
    Kim GD; Oh J; Park HJ; Bae K; Lee SK
    Int J Oncol; 2013 Aug; 43(2):600-10. PubMed ID: 23708970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Schisandrin B protects against nephrotoxicity induced by cisplatin in HK-2 cells via Nrf2-ARE activation].
    Li M; Jin J; Li J; Guan CW; Wang WW; Qiu YW; Huang ZY
    Yao Xue Xue Bao; 2012 Nov; 47(11):1434-9. PubMed ID: 23387073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor activity of the proteasome inhibitor bortezomib in gastric cancer.
    Nakata W; Hayakawa Y; Nakagawa H; Sakamoto K; Kinoshita H; Takahashi R; Hirata Y; Maeda S; Koike K
    Int J Oncol; 2011 Dec; 39(6):1529-36. PubMed ID: 21785822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.